Literature DB >> 4795866

Cannabinoids. Structure-activity studies related to 1,2-dimethylheptyl derivatives.

B Loev, P E Bender, F Dowalo, E Macko, P J Fowler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4795866     DOI: 10.1021/jm00269a002

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  7 in total

1.  Chromenopyrazoles: non-psychoactive and selective CB₁ cannabinoid agonists with peripheral antinociceptive properties.

Authors:  Jose Cumella; Laura Hernández-Folgado; Rocio Girón; Eva Sánchez; Paula Morales; Dow P Hurst; Maria Gómez-Cañas; Maria Gómez-Ruiz; Diana C G A Pinto; Pilar Goya; Patricia H Reggio; María Isabel Martin; Javier Fernández-Ruiz; Artur M S Silva; Nadine Jagerovic
Journal:  ChemMedChem       Date:  2012-02-02       Impact factor: 3.466

2.  (-)-8beta-hydroxymethyl-delta1-tetrahydrocannabinol: a novel physiologically active analog of delta1-tetrahydrocannabinol.

Authors:  R K Razdan; J F Howes; D B Uliss; H C Dalzell; G R Handrick; W L Dewey
Journal:  Experientia       Date:  1976-04-15

3.  Identification of essential cannabinoid-binding domains: structural insights into early dynamic events in receptor activation.

Authors:  Joong-Youn Shim; Alexander C Bertalovitz; Debra A Kendall
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

4.  W10294A: a new bronchodilator.

Authors:  M R Littner
Journal:  Lung       Date:  1977       Impact factor: 2.584

Review 5.  Role of cannabinoids in the treatment of pain and (painful) spasticity.

Authors:  Matthias Karst; Sonja Wippermann; Jörg Ahrens
Journal:  Drugs       Date:  2010-12-24       Impact factor: 9.546

6.  Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4.

Authors:  Robert B Zurier; Yee-Ping Sun; Kerri L George; Judith A Stebulis; Ronald G Rossetti; Ann Skulas; Erica Judge; Charles N Serhan
Journal:  FASEB J       Date:  2009-01-05       Impact factor: 5.191

7.  Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of LenabasumTM.

Authors:  Spandana Maddukuri; Jay Patel; De Anna Diaz; Kristen L Chen; Maria Wysocka; Christina Bax; Yubin Li; Adarsh Ravishankar; Madison Grinnell; Majid Zeidi; Nithin Reddy; Josef Symon S Concha; Muhammad M Bashir; Joyce Okawa; Barbara White; Victoria P Werth
Journal:  Arthritis Res Ther       Date:  2022-01-04       Impact factor: 5.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.